Feng F - Search Results

1

Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate.

Feng F, Zheng D, Zhang D, Duan C, Wang Y, Jia L, Wang F, Liu Y, Gao Q, Zhang Q. Feng F, et al. J Microencapsul. 2011;28(4):280-5. doi: 10.3109/02652048.2011.559285. J Microencapsul. 2011. PMID: 21545318

2

Preparation and characterization of silybin-loaded nanostructured lipid carriers.

Jia LJ, Zhang DR, Li ZY, Feng FF, Wang YC, Dai WT, Duan CX, Zhang Q. Jia LJ, et al. Drug Deliv. 2010 Jan;17(1):11-8. doi: 10.3109/10717540903431586. Epub 2009 Nov 26. Drug Deliv. 2010. PMID: 19941406 Free article.

3

Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

Dai W, Zhang D, Duan C, Jia L, Wang Y, Feng F, Zhang Q. Dai W, et al. Among authors: feng f. J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526. J Microencapsul. 2010. PMID: 20113167

4

Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.

Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q. Jia L, et al. Among authors: feng f. Colloids Surf B Biointerfaces. 2010 Oct 15;80(2):213-8. doi: 10.1016/j.colsurfb.2010.06.008. Epub 2010 Jun 23. Colloids Surf B Biointerfaces. 2010. PMID: 20621458

5

Development and in vitro characterizations of bifendate nanosuspensions.

Liu Y, Zhang D, Zou D, Wang Y, Duan C, Jia L, Xie P, Feng F, Wang F, Zhang X, Zhang Q. Liu Y, et al. Among authors: feng f. J Biomed Nanotechnol. 2011 Oct;7(5):621-31. doi: 10.1166/jbn.2011.1330. J Biomed Nanotechnol. 2011. PMID: 22195479

6

Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension.

Feng FF, Zhang DR, Tian KL, Lou HY, Qi XL, Wang YC, Duan CX, Jia LJ, Wang FH, Liu Y, Zhang Q. Feng FF, et al. Drug Deliv. 2011 May;18(4):265-71. doi: 10.3109/10717544.2010.536271. Epub 2010 Nov 24. Drug Deliv. 2011. PMID: 21091387 Free article.

7

In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.

Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. Wang Y, et al. Among authors: feng f. Nanotechnology. 2010 Apr 16;21(15):155104. doi: 10.1088/0957-4484/21/15/155104. Epub 2010 Mar 23. Nanotechnology. 2010. PMID: 20332565

8

Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.

Wang Y, Liu Z, Zhang D, Gao X, Zhang X, Duan C, Jia L, Feng F, Huang Y, Shen Y, Zhang Q. Wang Y, et al. Among authors: feng f. Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):189-97. doi: 10.1016/j.colsurfb.2010.10.029. Epub 2010 Oct 21. Colloids Surf B Biointerfaces. 2011. PMID: 21176876

9

Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting.

Duan C, Zhang D, Wang F, Zheng D, Jia L, Feng F, Liu Y, Wang Y, Tian K, Wang F, Zhang Q. Duan C, et al. Among authors: feng f. Int J Pharm. 2011 May 16;409(1-2):252-9. doi: 10.1016/j.ijpharm.2011.02.050. Epub 2011 Feb 26. Int J Pharm. 2011. PMID: 21356283

10

In vitro and in vivo antitumor activity of oridonin nanosuspension.

Lou H, Zhang X, Gao L, Feng F, Wang J, Wei X, Yu Z, Zhang D, Zhang Q. Lou H, et al. Among authors: feng f. Int J Pharm. 2009 Sep 8;379(1):181-6. doi: 10.1016/j.ijpharm.2009.06.022. Epub 2009 Jun 27. Int J Pharm. 2009. PMID: 19563872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,841 results

Search Page

Filters